Join ICON Biotech at OCT East Coast 2026, taking place 12–13 May 2026 at the Hyatt Regency New Brunswick, New Jersey. Meet our team at Booth \#25 and explore how our specialised clinical development services can suppor...

If recruitment and retention matter, site satisfaction must be treated as a prerequisite. In this Journal for Clinical Studies article, Brian Mallon explains why start-up success is shaped by human factors, not technolog...

Ankita Minhas will speak on 6 May at OCT Europe in Barcelona at 12:00pm in Stream C. Her session will explore how leading biotechs manage rising complexity through AI-driven innovation, smarter trial designs, and stronge...

Do you struggle to keep on top of regulatory changes affecting the world of medicine and medical device clinical trials? Join thousands of subscribers who have discovered the convenience of our free monthly publication b...

Participant-centric study design has advanced, but site-centric execution has not kept pace. In the Journal for Clinical Studies, Brian Mallon examines how unclear expectations, administrative burden and contract delays ...

Oligonucleotide (ON) drug development is accelerating rapidly—but first in human (FIH) studies remain complex. Join our upcoming webinar to explore key translational and clinical considerations for initiating FIH antis...

Faster study start up starts with the right sites, and the right tools. Speak with us at ASCO, booth \#35093 to learn about ICON’s purpose built technology suite that helps sponsors identify, activate and collaborate wi...

Great discussion recently at European Pharmaceutical Review’s webinar, “Harnessing AI for more efficient clinical trials.” ICON’s SVP of Enterprise AI, Tony Clarke, joined a panel of industry leaders to share perspectiv...

On 5 May at SCDM EMEA, ICON’s Kevin Devenny will chair a session exploring why strong business processes and culture still matter, even as automation and AI continue to advance. The session will consider why technology ...

ICON Biotech will be at #OCTEU26 in Barcelona on 6–7 May. The conference unites biotech and clinical research leaders to explore the scientific and strategic forces shaping clinical development. Our biotech dedicated mo...

Only 1 week to go until the start of RAPS Euro Convergence 2026. The ICON team is looking forward to connecting with company and regulatory agency attendees who are navigating an increasingly complex regulatory landscape...

With the FDA’s launch of its generative AI tool Elsa, regulatory scrutiny is entering a new phase. On 5 May at SCDM EMEA, ICON’s Stephen Cameron will chair a session exploring what AI‑enabled inspections mean for clinica...